About 200 reports

  • China - Molecular Diagnostic Test Volume Application Share (Percent), 2011 - 2016
  • China - Molecular Diagnostic Application Market Share (Percent), 2011 - 2016

Further, Oncology Test has been categorized into three main types: Breast Cancer Testing, Colorectal Cancer Testing and Prostate Cancer Testing.

  • HPV Testing
  • Molecular Diagnostics
  • China
  • East Asia
  • OriGene Technologies, Inc.
  • 6.2.2 Colorectal Cancer Test Market
  • United States - Molecular Diagnostic Colorectal Cancer Testing Market (Million US$), 2010 - 2016

Oncology Test a) Breast Cancer ##) Molecular Diagnostics Market and Forecast ##) Segments Market & Forecast ##) Segments Test Volume & Forecast ##) Company Molecular Diagnostics Sales & Forecast b) Colorectal Cancer c) Prostate Cancer d) Others ##.

  • Molecular Diagnostics
  • North America
  • United States
  • bioMerieux S.A.
  • Cepheid

The collaboration has ensured Day-One patient access to FDA-approved molecular tests paired with newly approved drugs for cancer.

  • Molecular Diagnostics
  • World
  • Forecast
  • Market Size
  • Agilent Technologies, Inc.

LabCorp launched Epi proColon, a blood-based test for colorectal cancer screening that was approved on April ##, 2016 for clinical use by the U. S.

  • Molecular Diagnostics
  • World
  • Forecast
  • Market Size
  • Agendia, Inc.
  • SAUDI ARABIA dPCR AND qPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

Studies on DNA polymorphism, lung cancer and colorectal cancer used dPCR and qPCR techniques In order to assess mRNA expression of genes.

  • Molecular Diagnostics
  • World
  • Forecast
  • Market Size
  • Roche Group
  • 5.5.3 Phase III Clinical Trails
  • 5.5.2 Phase II Clinical Trails

US The Netherlands Cancer Institute The Drug Rediscovery Protocol (DRUP Trial) (DRUP) The aim was to describe the efficacy and toxicity of commercially available, targeted anticancer drugs on advanced cancer patients and to perform next generation sequencing on tumor biopsies US En

  • Molecular Diagnostics
  • Europe
  • World
  • Forecast
  • Market Size

Other risk factors associated with Clostridium difficile infection include surgery of the gastrointestinal (GI) tract, diseases of the colon, such as inflammatory bowel disease or colorectal cancer, weakened immune system, use of chemotherapy drugs, previous Clostridium difficile i

  • Immunodiagnostics
  • Molecular Diagnostics
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Olympus Corporation

Phase IV ##. ##. ## CLINICAL TRIALS ANALYSIS FIGURE ##: EXPERT OPINIONS ##. ##. ## PHASE II CLINICAL TRAILS TABLE ##: PHASE II CLINICAL TRAILS US The Drug Rediscovery Protocol (DRUP Trial) (DRUP) A Randomized, ##x## Factorial Design Biomarker Prevention Trial of Lowdose Aspirin and Metformin in Stage I-

  • Molecular Diagnostics
  • World
  • Forecast
  • Market Size
  • Illumina, Inc.

The most common types of cancers in India include breast, cervical, oral cavity, lung, and colorectal cancer.

  • Molecular Diagnostics
  • North America
  • United States
  • World
  • Market Size

Molecular Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025 ##.

  • Diagnostics
  • Molecular Diagnostics
  • APAC
  • World
  • Market Size
  • Molecular Diagnostics Market and Forecast - 9 Applications Segment Covered

Oncology Bladder Cancer Breast Cancer Cervical Cancer Colorectal Cancer Molecular Diagnostics Market and Forecast - ## Technological Segments Covered Ovarian Cancer Prostate Cancer All Other Cancers ##.

  • Molecular Diagnostics
  • bioMerieux S.A.
  • Cepheid
  • Hologic, Inc.
  • Myriad Genetics, Inc.

REST OF WORLD PART D: ANNEXURE ##.

  • Molecular Diagnostics
  • APAC
  • United States
  • World
  • Market Shares

Cancer Incidence and Prevalence by Type ##-## ##. ## Breast cancer ##-## ##. ## Prostate cancer ##-## ##. ## Lung cancer ##-## ##. ## Colorectal cancer ##-## ##. ## Melanoma ##-## ##. ## Pancreatic cancer ##-## ##. ## Hepatocellular cancer ##-## ##. ## Cer

  • Diagnostics
  • Molecular Diagnostics
  • World
  • Forecast

An FOBT also called as guaiac test, is a widely used screening tool for colorectal cancer.

  • Molecular Diagnostics
  • World
  • Market Size
  • bioMerieux S.A.
  • Danaher Corporation

BLOOD IN THE STOOL MAY BE A SIGN OF COLORECTAL CANCER OR OTHER PROBLEMS, SUCH AS ULCERS OR POLYPS, WHICH ARE GROWTHS THAT DEVELOP ON THE INNER WALL OF THE COLON AND RECTUM.

  • Molecular Diagnostics
  • Latin America
  • Mexico
  • North America
  • Forecast

Disease – China Molecular Diagnostic Test Volume ##. ## Oncology Test Volume ##. ##. ## Breast Cancer Test Volume ##. ##. ## Colorectal Cancer Test Volume ##. ##. ## Prostate Cancer Test Volume ##. ## Infectious Disease Test Volume ##. ##. ## Virology Test Volume ##. ##. ## HPV Test Volume ##. ##

  • Diagnostics
  • Molecular Diagnostics
  • Pathology
  • China
  • Market Shares

BLOOD IN THE STOOL MAY BE A SIGN OF COLORECTAL CANCER OR OTHER PROBLEMS, SUCH AS ULCERS OR POLYPS, WHICH ARE GROWTHS THAT DEVELOP ON THE INNER WALL OF THE COLON AND RECTUM.

  • Molecular Diagnostics
  • Eastern Europe
  • Russia
  • Forecast
  • bioMerieux S.A.
  • Global oncology molecular diagnostics market segmentation by cancer type
  • Other prominent vendors

Colorectal cancer can be treated by surgery, radiation, or cancer drugs.

  • Medical Biotechnology
  • Molecular Diagnostics
  • Becton Property Group
  • QIAGEN N.V.
  • Roche Group

Oncology ##. ##. ##. ## Oncology market, 2014 - 2026 (USD Million) ##. ##. ##. ## Breast cancer ##. ##. ##. ##. ## Breast cancer market, 2014 - 2026 (USD Million) ##. ##. ##. ## Prostate cancer ##. ##. ##. ##. ## Prostate cancer market, 2014 - 2026 (USD Million) ##. ##. ##. ## Colorectal

  • Diagnostics
  • Medical Biotechnology
  • Molecular Diagnostics
  • United States
  • Forecast
  • GLOBAL OTHER PCR-BASED MOLECULAR ASSAYS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • 9. GLOBAL TRANSPLANT DIAGNOSTICS MARKET ANALYSIS- BY TECHNOLOGY

The cancer such as cervical and colorectal cancer are the commonly found cancers in the country.

  • Molecular Diagnostics
  • World
  • Forecast
  • Market Size
  • Illumina, Inc.

Cancer is one of the leading causes of death in Japan.

  • Molecular Diagnostics
  • North America
  • United States
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.

On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others.

  • Molecular Diagnostics
  • North America
  • United States
  • World
  • Market Size
  • GLOBAL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGIES IN $MILLON (2016-2026)
  • Global Molecular Diagnostics Market Size by technologies in $million (2016-2026)

Oncological diseases such as breast cancer, prostate cancer, colorectal cancer, lung cancer etc., respiratory diseases such as cystic fibrosis etc.

  • Molecular Diagnostics
  • Becton Property Group
  • bioMerieux S.A.
  • QIAGEN N.V.
  • Roche Group
  • MARKETED COMPANION DIAGNOSTIC TESTS, US, 2018 (3/5)

COLORECTAL CANCER: COMPETITIVE LANDSCAPE TO 2026, APRIL 2018, GDHC##CL GLOBALDATA (2017).

  • Molecular Diagnostics
  • Abbott Molecular Inc.
  • Foundation Medicine, Inc.
  • Roche Group
  • Ventana Medical Systems, Inc.

ELECTRICAL SIGNATURES ARE PRODUCED WHEN THE CANCER CELL BINDS TO ONE OF THE ATTACHED ANTIBODIES.

  • Molecular Diagnostics
  • World
  • Market Size
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Global molecular diagnostics market by blood testing
  • Global molecular diagnostics market by blood testing 2015-2020 ($ billions)

Colox, a new generation cancer diagnostic test, determines the expression of ## genes in peripheral blood mononuclear cells (PBMCs), thereby enabling early detection of colorectal cancer.

  • Medical Biotechnology
  • Molecular Diagnostics
  • World
  • QIAGEN N.V.
  • Roche Group

In Situ Hybridization is expected to witness the fastest growth over the forecast period owing to the factors such as increase in the size of cancer affected population and need for early cancer diagnosis.

  • Diagnostics
  • Medical Biotechnology
  • Molecular Diagnostics
  • United States
  • Market Size
  • OTHERS

IN WOMEN BREAST, COLORECTAL, LUNGS, CERVIX AND STOMACH ARE THE COMMON SITES OF THE CANCER DIAGNOSIS.

  • Molecular Diagnostics
  • World
  • Market Size
  • Agilent Technologies, Inc.
  • GE Healthcare Limited

Cancer ## Cardiovascular Diseases ## Chlamydia Trachomatis Infection ## Gastrointestinal Disease ## Human Immunodeficiency Virus Infection ## Human Papilloma Virus Infection ## Neisseria Gonorrhoeae Infection ## Sepsis ## Sexua

  • Biotech Diagnostics
  • Molecular Diagnostics
  • United States
  • World
  • Rheonix, Inc.

Lynn Cancer Institute is one of the largest cancer ##.

  • Molecular Diagnostics
  • United States
  • Cepheid
  • PerkinElmer, Inc.
  • Quidel Corporation